Tissue Regenix Group plc (LON:TRX – Get Free Report) shares hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 35 ($0.45) and last traded at GBX 35.42 ($0.46), with a volume of 27614 shares changing hands. The stock had previously closed at GBX 36.50 ($0.47).
Tissue Regenix Group Stock Performance
The stock has a market cap of £33.36 million, a price-to-earnings ratio of -38.20 and a beta of 1.61. The company’s 50 day simple moving average is GBX 49.40 and its 200 day simple moving average is GBX 54.75. The company has a debt-to-equity ratio of 31.16, a quick ratio of 2.36 and a current ratio of 4.03.
Tissue Regenix Group Company Profile
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Further Reading
- Five stocks we like better than Tissue Regenix Group
- What is a Stock Market Index and How Do You Use Them?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- How to trade using analyst ratings
- Top 3 Beverage Stocks Pouring Out Profits
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
